Active	Status	Sponsor type	Region	Phase	Filter
3 Active 0 Inactive 3 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes: « May » « 2025 » M T W T F S S 28 29 30 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 1   - « May » « 2025 » M T W T F S S 28 29 30 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 1   Show only changed items Enrollment:

Advanced Filters

3 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Gbohunmi, Adeyemi
NCT06568042: Effects of LY3848575 Versus Placebo in Participants With Painful Distal Sensory Polyneuropathy	Recruiting	2	450	Europe, Canada, Japan, US, RoW	LY3848575, Placebo	Eli Lilly and Company	Neuropathic Pain, Distal Sensory Polyneuropathy	06/26	09/26
NCT06268860: A Study to Assess Bioavailability of Rocatinlimab (AMG 451) Vial and Prefilled Syringe in Healthy Participants	Completed	1	240	Europe, US	Rocatinlimab vial injection, AMG 451, Rocatinlimab prefilled syringe	Amgen	Atopic Dermatitis	08/24	08/24
ATH-1105-0101, NCT06432647: A SAD and MAD Study of the Safety, Tolerability, and Pharmacokinetics of ATH-1105	Recruiting	1	80	US	ATH-1105, Placebo	Athira Pharma, Fortrea Holdings, Inc.	Healthy Volunteers	10/24	10/24

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Gbohunmi, Adeyemi
NCT06568042: Effects of LY3848575 Versus Placebo in Participants With Painful Distal Sensory Polyneuropathy	Recruiting	2	450	Europe, Canada, Japan, US, RoW	LY3848575, Placebo	Eli Lilly and Company	Neuropathic Pain, Distal Sensory Polyneuropathy	06/26	09/26
NCT06268860: A Study to Assess Bioavailability of Rocatinlimab (AMG 451) Vial and Prefilled Syringe in Healthy Participants	Completed	1	240	Europe, US	Rocatinlimab vial injection, AMG 451, Rocatinlimab prefilled syringe	Amgen	Atopic Dermatitis	08/24	08/24
ATH-1105-0101, NCT06432647: A SAD and MAD Study of the Safety, Tolerability, and Pharmacokinetics of ATH-1105	Recruiting	1	80	US	ATH-1105, Placebo	Athira Pharma, Fortrea Holdings, Inc.	Healthy Volunteers	10/24	10/24